Virginia Commonwealth University is working on the development of a potential treatment for Covid-19.
Michael Peters, Ph.D., a professor in VCU’s Department of Chemical and Life Science Engineering, is leading the research.
Peters said he works everyday in response to the pandemic, which led him to the discovery of a possible lifesaving novel peptide therapeutic that could slow the transmission of Covid-19.
The research caught the attention of biopharmaceutical company Hoth Therapeutics, and recently led to a licensing deal.
“VCU Innovation Gateway and Dr. Peters partnered with Hoth Therapeutics to further develop Dr. Peters’ technology and bring new treatment to the market,” Magdalena Morgan, director of licensing at VCU Innovation Gateway told Inno. “The research is still ongoing but moving forward quickly.”
She added, “Development of new therapeutics is a not an easy and straight forward process, but we remain optimistic that together we can bring this therapy…
Read the full story from the Washington Business Journal.
